Sintx Technologies, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $10.3M
- Price
- $1.55
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.65%
- Volume
- 25.5K
About
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
Quick stats
Shares outstanding6.7M
Computed float4.9M
Float / shares73.1%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001269026
Websitehttps://www.sintx.com
AI Summary
AI-generated1/12
minorbullishregulatory
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
SINTX Technologies regained compliance with Nasdaq Listing Rule 5550(b)(1) after its Form 10-Q for the quarter ended June 30, 2026, reported stockholders' equity of approximately $4.83 million.
This equity figure exceeds the Nasdaq Capital Market minimum requirement of $2.5 million, officially closing the previously disclosed deficiency matter.
CEO Eric K. Olson stated the resolution is an important step as the company focuses on commercializing its silicon nitride technologies and executing its growth strategy.